Both the pollen extract and Eviprostat significantly reduced the symptoms of category III CP/CPPS without any adverse events. Eviprostat may have an identical effect on category III CP/CPPS compared the pollen extract.
The study was registered with the University Hospital Medical Information Network Clinical Trials Registry in Japan (UMIN000019618); registration date: 3 November 2015.
CP: chronic prostatitis; CPPS: chronic pelvic pain syndrome; hps: high-power field; IPSS: International Prostate Symptom Index; MDA: malondialdehyde; NBP: non-bacterial prostatitis; NIH: National Institutes of Health; NIH-CPSI: NIH-Chronic Prostatitis Symptom Index; PPMT: pre and post massage test; QOL: quality of life; STD: sexually transmitted disease; VB3: prostate massage urine specimen; WBC: white blood cells.
We would like to acknowledge the support and assistance provided by all the staff of the Department of Urology, Hirosaki University Graduate School of Medicine.
BMC Urol. 2015;15(120) © 2015 BioMed Central, Ltd.